P&F secures CE Mark Certification under the EU Medical Device Regulation (MDR) 2017/745 regulations for TricValve® Bicaval Valve System, A Breakthrough Minimally Invasive Therapy for Severe Tricuspid Regurgitation Vienna, Austria, Feb. 5, 2026 — P&F Products and Features GmbH, a global heart valve MedTech company
TRICAV II will evaluate the safety and effectiveness of the TricValve® Transcatheter Bicaval Valve System Wilmington, Delaware, Dec. 12, 2025 — P&F USA, Inc., the U.S. subsidiary of global heart valve manufacturer P&F Products and Features GmbH, today announced that the U.S. Food and Drug
San Francisco, CA — October 2025 The global forum for interventional cardiology, Transcatheter Cardiovascular Therapeutics (TCT) conference, once again brought together the world’s leading experts in interventional cardiovascular medicine to explore the latest breakthroughs in patient care. As the foremost educational forum organized by the
